CEO Roundtable on Cancer - CEO ROUNDTABLE HOME

CEO ROUNDTABLE HOME

Our Mission

The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem. Members of the CEO Roundtable collaboratively work to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate better access to best-available treatments, and hasten the discovery of novel and more effective diagnostic tools and anti-cancer therapies.

Partnership across multiple sectors will speed new therapies to cancer patients

The CEO Roundtable on Cancer, in partnership with the National Cancer Institute and academic institutions across the country, is making freely available a set of common contract clauses designed to reduce the length of time it takes before cancer clinical trials may begin.

Table of Contents:

Document: Proposed Standardized/Harmonized Clauses for Clinical Trial Agreements

Press release: CEO Roundtable on Cancer announcing the availability of “common clauses” for clinical trial agreements (October 10, 2008)

Department of Justice Letter: Review of proposal to develop and publicize model clauses for use in agreements governing clinical trials of potential new cancer treatments (September 17, 2008)

Press release: Department of Justice Ruling: “Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal” (September 17, 2008)

Wall Street Journal: Health Blog on “common clauses” (September 19, 2008)

Note: In order to provide you with additional information as it becomes available, please complete the simple registration. Your information will not be shared for any reason.

To download documents, click HERE

Click HERE to view the Vendor Endorsement Policy

News

CEO Roundtable on Cancer Offers “Common Language” to Jump Start Cancer Clinical Trials

- Partnership with National Cancer Institute, academic centers and industry
could speed new therapies to cancer patients -

CARY, NC (October 10, 2008) – Potentially life-lengthening cancer therapies could enter clinical trials and ultimately reach cancer patients dramatically faster thanks to legal contract language created by the CEO Roundtable on Cancer, a nonprofit group of cancer-fighting CEOs. The group hopes to shorten the drug testing process by making available “common language” for clinical trial contracts through a set of standardized contract templates for use by NCI-designated cancer centers and the pharmaceutical industry. Click here for more information on the complete report and related documents.

CEO Roundtable on Cancer members and staff are deeply saddened by the loss of one of our members and a longtime champion in the fight against cancer, The Honorable Paul G. Rogers who passed away on October 13 in Washington, D.C. Paul was a former Florida congressman and partner of the law firm of Hogan & Hartson. Our deep condolences are offered to Paul’s wife Becky, his family and extended family at Hogan & Hartson. In tribute to Paul, this page will be updated with homages and personal tributes honoring his life and legacy. If you would like to submit a personal tribute, please reply to: This email address is being protected from spam bots, you need Javascript enabled to view it

To read tributes to Paul Rogers and other information, please click here.